These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 15998418)
1. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Kao JH; Chen DS Liver Int; 2005 Aug; 25(4):696-703. PubMed ID: 15998418 [TBL] [Abstract][Full Text] [Related]
2. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109 [TBL] [Abstract][Full Text] [Related]
3. East Asia expert opinion on treatment initiation for chronic hepatitis B. Kao JH; Hu TH; Jia J; Kurosaki M; Lim YS; Lin HC; Sinn DH; Tanaka Y; Wai-Sun Wong V; Yuen MF Aliment Pharmacol Ther; 2020 Nov; 52(10):1540-1550. PubMed ID: 32951256 [TBL] [Abstract][Full Text] [Related]
4. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term. Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226 [TBL] [Abstract][Full Text] [Related]
5. Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications. Tran NH Curr Oncol Rep; 2022 Feb; 24(2):187-193. PubMed ID: 35061189 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Chen DS Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606 [TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis in East Asia. Chen DS J Formos Med Assoc; 1996 Jan; 95(1):6-12. PubMed ID: 8640098 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatocellular carcinoma. Yu MC; Yuan JM; Govindarajan S; Ross RK Can J Gastroenterol; 2000 Sep; 14(8):703-9. PubMed ID: 11185536 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and infections with multiple hepatitis viruses. Brunetto MR; Oliveri F; Colombatto P; Bonino F Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610 [TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C in Asia: when East meets West. Yu ML; Chuang WL J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971 [TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma, hepatitis B virus and the immune system]. Grob PJ Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937 [TBL] [Abstract][Full Text] [Related]
14. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Kew MC Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277 [TBL] [Abstract][Full Text] [Related]
16. [Alcoholic liver diseases in Japan and modification by hepatitis virus]. Horie Y; Yamagishi Y; Ishii H Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919 [TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of hepatocellular carcinoma in Asia. Goh GB; Chang PE; Tan CK Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253 [TBL] [Abstract][Full Text] [Related]
18. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820 [TBL] [Abstract][Full Text] [Related]
19. [Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis]. Abdurakhmanov DT Ter Arkh; 2013; 85(10):94-7. PubMed ID: 24437226 [TBL] [Abstract][Full Text] [Related]
20. The epidemiology and prevention of hepatocellular carcinoma. Monto A; Wright TL Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]